Health2 months ago
Vanda Pharmaceuticals Faces Challenges Ahead of Key PDUFA Decision
Vanda Pharmaceuticals Inc. reported disappointing results for the fiscal year 2025, revealing a significant GAAP EPS of -$2.39, which fell short of consensus estimates by approximately...
